These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 34127569)

  • 1. [Studies on Monoamine Transporter Occupancy of Antidepressants using PET: Focusing on SERT and NET].
    Matsuyama S; Arakawa R; Asami Y
    Brain Nerve; 2021 Jun; 73(6):731-736. PubMed ID: 34127569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.
    Takano A; Halldin C; Farde L
    Psychopharmacology (Berl); 2013 Mar; 226(1):147-53. PubMed ID: 23090625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
    Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor.
    Smith JA; Bourdet DL; Daniels OT; Ding YS; Gallezot JD; Henry S; Kim KH; Kshirsagar S; Martin WJ; Obedencio GP; Stangeland E; Tsuruda PR; Williams W; Carson RE; Patil ST
    Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults.
    Matuskey D; Gallezot JD; Nabulsi N; Henry S; Torres K; Dias M; Angarita GA; Huang Y; Shoaf SE; Carson RE; Mehrotra S
    J Psychopharmacol; 2023 Feb; 37(2):164-171. PubMed ID: 36515395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD.
    Ding YS; Naganawa M; Gallezot JD; Nabulsi N; Lin SF; Ropchan J; Weinzimmer D; McCarthy TJ; Carson RE; Huang Y; Laruelle M
    Neuroimage; 2014 Feb; 86():164-71. PubMed ID: 23933039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human serotonin and norepinephrine transporter occupancy of duloxetine by pharmacokinetic/pharmacodynamic modeling in the rat.
    Bourdet DL; Tsuruda PR; Obedencio GP; Smith JA
    J Pharmacol Exp Ther; 2012 Apr; 341(1):137-45. PubMed ID: 22235148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function.
    Zhao Y; Sun L
    J Clin Neurosci; 2008 Nov; 15(11):1264-9. PubMed ID: 18815045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography.
    Comley RA; Salinas CA; Slifstein M; Petrone M; Marzano C; Bennacef I; Shotbolt P; Van der Aart J; Neve M; Iavarone L; Gomeni R; Laruelle M; Gray FA; Gunn RN; Rabiner EA
    J Pharmacol Exp Ther; 2013 Aug; 346(2):311-7. PubMed ID: 23685546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and Norepinephrine Transporter Occupancy of Tramadol in Nonhuman Primate Using Positron Emission Tomography.
    Arakawa R; Takano A; Halldin C
    Int J Neuropsychopharmacol; 2019 Jan; 22(1):53-56. PubMed ID: 30346535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2.
    Moriguchi S; Takano H; Kimura Y; Nagashima T; Takahata K; Kubota M; Kitamura S; Ishii T; Ichise M; Zhang MR; Shimada H; Mimura M; Meyer JH; Higuchi M; Suhara T
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):957-962. PubMed ID: 29016875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans.
    Talbot PS; Bradley S; Clarke CP; Babalola KO; Philipp AW; Brown G; McMahon AW; Matthews JC
    Neuropsychopharmacology; 2010 Feb; 35(3):741-51. PubMed ID: 19890256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2.
    Sekine M; Arakawa R; Ito H; Okumura M; Sasaki T; Takahashi H; Takano H; Okubo Y; Halldin C; Suhara T
    Psychopharmacology (Berl); 2010 Jun; 210(3):331-6. PubMed ID: 20309528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.
    Takano H; Arakawa R; Nogami T; Suzuki M; Nagashima T; Fujiwara H; Kimura Y; Kodaka F; Takahata K; Shimada H; Murakami Y; Tateno A; Yamada M; Ito H; Kawamura K; Zhang MR; Takahashi H; Kato M; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):553-60. PubMed ID: 24345533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.
    Madras BK; Xie Z; Lin Z; Jassen A; Panas H; Lynch L; Johnson R; Livni E; Spencer TJ; Bonab AA; Miller GM; Fischman AJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):561-9. PubMed ID: 16885432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.
    Nyberg S; Jucaite A; Takano A; Kågedal M; Cselényi Z; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2235-44. PubMed ID: 23809226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET.
    Baldinger P; Kranz GS; Haeusler D; Savli M; Spies M; Philippe C; Hahn A; Höflich A; Wadsak W; Mitterhauser M; Lanzenberger R; Kasper S
    Neuroimage; 2014 Mar; 88():252-62. PubMed ID: 24121201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
    Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
    Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.
    Sørensen L; Andersen J; Thomsen M; Hansen SM; Zhao X; Sandelin A; Strømgaard K; Kristensen AS
    J Biol Chem; 2012 Dec; 287(52):43694-707. PubMed ID: 23086945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.